Charles Schwab
CVS icon

Charles Schwab’s CVS Health CVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$951M Buy
13,783,474
+135,601
+1% +$9.35M 0.16% 104
2025
Q1
$925M Buy
13,647,873
+728,924
+6% +$49.4M 0.17% 102
2024
Q4
$580M Buy
12,918,949
+710,281
+6% +$31.9M 0.11% 158
2024
Q3
$768M Buy
12,208,668
+304,386
+3% +$19.1M 0.15% 118
2024
Q2
$703M Buy
11,904,282
+366,909
+3% +$21.7M 0.13% 134
2024
Q1
$904M Sell
11,537,373
-1,412,916
-11% -$111M 0.21% 83
2023
Q4
$993M Buy
12,950,289
+232,464
+2% +$17.8M 0.25% 70
2023
Q3
$865M Buy
12,717,825
+324,391
+3% +$22.1M 0.25% 71
2023
Q2
$836M Buy
12,393,434
+397,285
+3% +$26.8M 0.24% 75
2023
Q1
$873M Sell
11,996,149
-58,860
-0.5% -$4.28M 0.27% 71
2022
Q4
$1.1B Buy
12,055,009
+155,280
+1% +$14.2M 0.36% 50
2022
Q3
$1.13B Buy
11,899,729
+224,538
+2% +$21.4M 0.41% 44
2022
Q2
$1.08B Sell
11,675,191
-24,093
-0.2% -$2.23M 0.38% 51
2022
Q1
$1.18B Buy
11,699,284
+134,457
+1% +$13.6M 0.36% 49
2021
Q4
$1.19B Buy
11,564,827
+559,559
+5% +$57.7M 0.35% 53
2021
Q3
$934M Buy
11,005,268
+84,565
+0.8% +$7.18M 0.31% 64
2021
Q2
$911M Buy
10,920,703
+187,276
+2% +$15.6M 0.3% 63
2021
Q1
$807M Sell
10,733,427
-102,220
-0.9% -$7.69M 0.3% 65
2020
Q4
$740M Sell
10,835,647
-18,526
-0.2% -$1.27M 0.29% 64
2020
Q3
$634M Sell
10,854,173
-506,535
-4% -$29.6M 0.29% 68
2020
Q2
$738M Sell
11,360,708
-5,615,306
-33% -$365M 0.36% 53
2020
Q1
$1.01B Buy
16,976,014
+5,078,541
+43% +$301M 0.59% 29
2019
Q4
$884M Buy
11,897,473
+220,868
+2% +$16.4M 0.48% 33
2019
Q3
$736M Buy
11,676,605
+360,308
+3% +$22.7M 0.43% 37
2019
Q2
$617M Buy
11,316,297
+491,729
+5% +$26.8M 0.38% 46
2019
Q1
$584M Buy
10,824,568
+619,236
+6% +$33.4M 0.37% 43
2018
Q4
$669M Buy
10,205,332
+2,414,491
+31% +$158M 0.51% 34
2018
Q3
$613M Buy
7,790,841
+458,176
+6% +$36.1M 0.41% 41
2018
Q2
$472M Buy
7,332,665
+300,887
+4% +$19.4M 0.34% 48
2018
Q1
$437M Buy
7,031,778
+2,720,334
+63% +$169M 0.34% 51
2017
Q4
$313M Buy
4,311,444
+71,916
+2% +$5.21M 0.25% 66
2017
Q3
$345M Buy
4,239,528
+219,536
+5% +$17.9M 0.3% 55
2017
Q2
$323M Buy
4,019,992
+273,574
+7% +$22M 0.3% 51
2017
Q1
$294M Buy
3,746,418
+40,014
+1% +$3.14M 0.29% 53
2016
Q4
$292M Buy
3,706,404
+258,981
+8% +$20.4M 0.32% 51
2016
Q3
$307M Buy
3,447,423
+32,623
+1% +$2.9M 0.36% 46
2016
Q2
$327M Buy
3,414,800
+44,554
+1% +$4.27M 0.41% 44
2016
Q1
$350M Buy
3,370,246
+64,666
+2% +$6.71M 0.46% 40
2015
Q4
$323M Buy
3,305,580
+88,738
+3% +$8.68M 0.44% 41
2015
Q3
$310M Sell
3,216,842
-14,331
-0.4% -$1.38M 0.46% 38
2015
Q2
$339M Buy
3,231,173
+57,547
+2% +$6.04M 0.47% 34
2015
Q1
$328M Buy
3,173,626
+115,841
+4% +$12M 0.46% 36
2014
Q4
$294M Buy
3,057,785
+105,035
+4% +$10.1M 0.44% 37
2014
Q3
$235M Buy
2,952,750
+79,403
+3% +$6.32M 0.39% 45
2014
Q2
$217M Buy
2,873,347
+34,417
+1% +$2.59M 0.36% 52
2014
Q1
$213M Buy
2,838,930
+95,969
+3% +$7.18M 0.38% 46
2013
Q4
$196M Buy
2,742,961
+6,861
+0.3% +$491K 0.37% 47
2013
Q3
$157M Buy
2,736,100
+110,465
+4% +$6.36M 0.32% 60
2013
Q2
$151M Buy
+2,625,635
New +$151M 0.34% 58